ProtonDx

London, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a portable molecular diagnostic platform designed to deliver rapid, laboratory-grade testing at the point of need. ProtonDx is based in London, United Kingdom and was founded in 2020. It has raised $11.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$11.4M
Last round
—

Who backs ProtonDx?

6 investors
InvestorType
Innovate UKOther
UK Research and InnovationOther
Imperial College London EndowmentOther
Imperial College London—
MedTech SuperConnector—
SBRI Healthcare—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ProtonDx investors

6 investors are on record for ProtonDx, including Innovate UK, UK Research and Innovation, Imperial College London Endowment and Imperial College London.

Free account
More of ProtonDx with a free account
  • ·Watch ProtonDx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like ProtonDx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View